Directors' Shareholdings / Issue of Equity

RNS Number : 1378P

Deltex Medical Group PLC

28 September 2011

 



 

 

Deltex Medical Group plc

Directors' Shareholdings/Issue of equity

28 September 2011 Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has yesterday issued a total of 343,617 new ordinary shares of 1p each in the Company ("New Ordinary Shares") at a price of 17.25 pence per share.

The four non-executive directors named below have elected to take New Ordinary Shares in lieu of a cash payment as remuneration for their services to the Company for the period 1 April 2011 to 30 September 2011.

Paul Mitchell has elected to take New Ordinary Shares in lieu of £5,408 of salary in respect of the period 1 April 2011 to 30 September 2011.

In addition to the above, the Company also announces that it has today issued a total of 68,817 New Ordinary Shares to a certain adviser of the Company at a price of 17.25 pence per share.

Accordingly, application has been made for these New Ordinary Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on Tuesday 4 October 2011.  Following the issue of these new shares the Company has a total of 138,325,461 ordinary shares of 1p each in issue.

Following this issue, the directors' beneficial interests are as follows:

Name of Director	Number of New Ordinary Shares issued in lieu of fees/salary	Holding of shares following issue of New Ordinary Shares	% of enlarged issued share capital
Nigel Keen	96,617	5,759,660	4.16
Dr Edwin Snape	69,565	1,116,338	0.81
Sir Duncan Nichol	34,783	647,416	0.47
Julian Cazalet	55,652	3,527,882	2.55
Paul Mitchell	18,183	154,219	0.11

For further information, please contact:-

Deltex Medical Group plc                                                                                01243 774 837
Nigel Keen, Chairman                                        
Ewan Phillips, Chief Executive                           
Paul Mitchell, Finance Director               

Nominated Adviser and Broker                                                                        0207 614 5917

Arden Partners plc 

Christopher Hardie

Jamie Cameron

 

END

 

 

RDSLPMFTMBMTBAB